We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,574 results
  1. Dextromethorphan

    Reference work entry 2024
  2. A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor

    Purpose

    A therapeutic agent that targets both viral replication and the hyper-reactive immune response would offer a highly desirable treatment for...

    Terri L. Morton, Oscar L. Laskin, ... Ronald Kong in European Journal of Clinical Pharmacology
    Article Open access 06 June 2023
  3. Anti-epileptic and Neuroprotective Effects of Ultra-low Dose NADPH Oxidase Inhibitor Dextromethorphan on Kainic Acid-induced Chronic Temporal Lobe Epilepsy in Rats

    Neuroinflammation mediated by microglia and oxidative stress play pivotal roles in the development of chronic temporal lobe epilepsy (TLE). We...

    **g-**g Yang, Ying-**n Liu, ... Jie Zhao in Neuroscience Bulletin
    Article 16 November 2023
  4. Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers

    The primary objectives of this study were to investigate the suitability of a 6-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan,...

    Seok Hwee Koo, Gaik Hong Soon, ... Daphne Shih Wen Ang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 08 April 2022
  5. Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis

    Abstract

    The outbreak of novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus...

    Preeti Pandey, Kartikay Prasad, ... Vijay Kumar in Journal of Molecular Medicine
    Article 23 September 2020
  6. Design and Optimization of Novel Taste-Masked Medicated Chocolates of Dextromethorphan with In vitro and In vivo Taste Evaluation

    Purpose

    Dextromethorphan (DXM) is exceptionally bitter, yet the most widely used antitussive agents worldwide. It belongs to BCS class-II of...

    Rahat Fatima Naqvi, Ahmad Khan, ... Nisar Ahmad Shahwani in Journal of Pharmaceutical Innovation
    Article 02 November 2020
  7. Antitumor Effect of Traditional Drugs for Neurological Disorders: Preliminary Studies in Neural Tumor Cell Lines

    Glioblastoma multiforme is the most common malignant primary brain tumor in adults. Despite new treatments developed including immunomodulation using...

    Kevin Doello, Cristina Mesas, ... Raúl Ortiz in Neurotoxicity Research
    Article Open access 30 November 2022
  8. The IC87201 (a PSD95/nNOS Inhibitor) Attenuates Post- Stroke Injuries

    N-methyl-D-aspartate receptor-dependent excitotoxicity is one of the most important mechanisms underlying stroke injury and the resulting neuronal...

    Maryam Mohammadian, Aminollah Bahaoddini, Mohammad Reza Namavar in Neurochemical Research
    Article 24 April 2024
  9. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan

    Rationale

    Although both psilocybin and dextromethorphan (DXM) produce psychedelic-like subjective effects, rates of non-medical use of psilocybin are...

    Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths in Psychopharmacology
    Article 05 June 2020
  10. Multi-faceted Anti-obesity Effects of N-Methyl-D-Aspartate (NMDA) Receptor Modulators: Central-Peripheral Crosstalk

    Hypothalamus is central to food intake and satiety. Recent data unveiled the expression of N-methyl-D-aspartate receptors (NMDAR) on hypothalamic...

    Shruti Subhash Shiromwar, Vijay R. Chidrawar, ... Shabnam Sultana in Journal of Molecular Neuroscience
    Article 19 January 2024
  11. The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review

    Objectives

    Linezolid is a commonly used antibiotic in the clinical treatment of gram-positive bacterial infections. The impacts of drug interactions...

    Qiang Xu, Yanlei Sang, ... Lu Li in European Journal of Clinical Pharmacology
    Article 29 February 2024
  12. Opioid toxicity: histamine, hypersensitivity, and MRGPRX2

    Insights into the pathophysiology of many non-immune-mediated drug reactions referred to as toxicities, sensitivities, intolerances, or...

    Brian A. Baldo, Nghia H. Pham in Archives of Toxicology
    Article 07 November 2022
  13. Ten Years of Robotrip**: Evidence of Tolerance to Dextromethorphan Hydrobromide in a Long-Term User

    Introduction

    Dextromethorphan hydrobromide is widely available as an over-the-counter cough suppressant. A semi-synthetic opioid displaying N -methyl- d ...

    Travis D. Olives, Sean P. Boley, ... Samuel J. Stellpflug in Journal of Medical Toxicology
    Article 22 March 2019
  14. A cocktail probe approach to evaluate the effect of hormones on the expression and activity of CYP enzymes in human hepatocytes with conditions simulating late stage of pregnancy

    Purpose

    Pregnancy-mediated physiological and biochemical changes contribute to alterations in the pharmacokinetics of certain drugs. There is a...

    Ali Alshabi, Imam H. Shaik, ... Raman Venkataramanan in European Journal of Clinical Pharmacology
    Article 15 April 2023
  15. Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing

    Most transcriptome-wide association studies (TWASs) so far focus on European ancestry and lack diversity. To overcome this limitation, we aggregated...

    Fang Chen, **ngyan Wang, ... Dajiang J. Liu in Nature Genetics
    Article Open access 26 January 2023
  16. The Glutamatergic System as a Target for the Development of New Pharmacological Treatments of Bipolar Disorder

    Bipolar affective disorder is a relatively common psychiatric disorder that affects millions of people worldwide. Existing antidepressants and mood...
    Grigorios N. Karakatsoulis, Konstantinos N. Fountoulakis in Glutamate and Neuropsychiatric Disorders
    Chapter 2022
  17. Emotional and Neuropsychiatric Disorders Associated with Alzheimer’s Disease

    Alzheimer’s disease is associated with impairments in emotional communication including comprehension and production of facial emotional expressions,...

    Kenneth M. Heilman, Stephen E. Nadeau in Neurotherapeutics
    Article 10 January 2022
  18. Novel Mechanism, Drug Target and Therapy in Epilepsy

    Cenglin Xu, Yi Wang, Zhong Chen in Neuroscience Bulletin
    Article 24 April 2024
  19. Intermittent Hypoxia Activates N-Methyl-D-Aspartate Receptors to Induce Anxiety Behaviors in a Mouse Model of Sleep-Associated Apnea

    Sleep apnea disrupts physiologic homeostasis and causes neuronal dysfunction. In addition to signs of mental disorders and cognitive dysfunction,...

    Yun Fan, Mei-Chuan Chou, ... Shiou-Lan Chen in Molecular Neurobiology
    Article 04 March 2021
  20. Opioids-Induced Long QT Syndrome: A Challenge to Cardiac Health

    The challenge posed by opioid overdose has become a significant concern for health systems due to the complexities associated with drug prohibition,...

    Jiale Hu, Yongfei Song, ... Jiangfang Lian in Cardiovascular Toxicology
    Article Open access 17 April 2024
Did you find what you were looking for? Share feedback.